Literature DB >> 9415674

Adenosine plasma levels after low dose methotrexate administration.

F Laghi Pasini, P L Capecchi, T Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9415674

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Methotrexate modulates the kinetics of adenosine in humans in vivo.

Authors:  N P Riksen; P Barrera; P H H van den Broek; P L C M van Riel; P Smits; G A Rongen
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

2.  Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.

Authors:  Avivit Ochaion; Sara Bar-Yehuda; Shira Cohn; Luis Del Valle; Georginia Perez-Liz; Lea Madi; Faina Barer; Motti Farbstein; Sari Fishman-Furman; Tatiana Reitblat; Alexander Reitblat; Howard Amital; Yair Levi; Yair Molad; Reuven Mader; Moshe Tishler; Pnina Langevitz; Alexander Zabutti; Pnina Fishman
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

3.  Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis.

Authors:  M Carmen Montesinos; Avani Desai; Bruce N Cronstein
Journal:  Arthritis Res Ther       Date:  2006-03-06       Impact factor: 5.156
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.